Cargando…
Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus
The development of a safe and effective Zika virus (ZIKV) vaccine has become a global health priority since the widespread epidemic in 2015-2016. Based on previous experience in using the well-characterized and clinically proven dengue virus serotype-2 (DENV-2) PDK-53 vaccine backbone for live-atten...
Autores principales: | Baldwin, Whitney R., Giebler, Holli A., Stovall, Janae L., Young, Ginger, Bohning, Kelly J., Dean, Hansi J., Livengood, Jill A., Huang, Claire Y.-H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677809/ https://www.ncbi.nlm.nih.gov/pubmed/34916486 http://dx.doi.org/10.1038/s41467-021-27578-w |
Ejemplares similares
-
Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
por: Baldwin, Whitney R., et al.
Publicado: (2018) -
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of Protection
por: Young, Ginger, et al.
Publicado: (2020) -
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
por: Kum, Dieudonné B., et al.
Publicado: (2018) -
A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple species
por: Bohning, Kelly, et al.
Publicado: (2021) -
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function
por: Tsuji, Isamu, et al.
Publicado: (2022)